Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Zhehai Wang
483
•Zhehai Wang•October 18, 2021

Zhehai Wang – FDA 483, Oct 18, 2021

Record Details

An FDA inspection of Zhehai Wang, a clinical investigator in Jinan, China, revealed a significant issue regarding the conduct of an investigation. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. This indicates a serious deviation from protocol requirements for clinical trials.

Company
Zhehai Wang
Inspection date
October 18, 2021
Product type
drugs
Office
Beijing China District Office
Person
  • Marijo B. Kambere
View Company Profile

ID · d82ee499-f371-4126-bdf5-2a32eb233e3b

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zhehai Wang
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.